peripherally-induced neuropathic pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age =18 years old, gender unlimited; (2) peripheral nerve related pain; (3) 24-hour average pain (BIP#5) =5 points per day in the past 3 days; (4) Not participating in other clinical trials within the past 3 months; (5) Be able to understand the purpose of the test and voluntarily sign the informed consent; (6) The subjects are willing to undergo follow-up evaluation as required by the protocol.
Exclusion criteria
Exclusion criteria: (1) There is mental or cognitive impairment or no autonomous behavioral ability, unable to cooperate with researchers; An accurate assessment of the effectiveness and safety of the device; (2) Those who have implanted deep brain stimulation system, pacemaker, defibrillator and other stimulation current pathways overlapping with peripheral nerve stimulation electrodes; (3) diseases that increase the risk of infection (e.g. valvular heart disease, compromised immune system, history of recurrent skin infections); (4) analgesic drug dependence; (5) Patients who have undergone surgery within 1 month; (6) Patients who are allergic to tapes and adhesives; (7) Women who are pregnant or breastfeeding, or who plan to become pregnant during the study period; (8) Those who were not considered suitable for inclusion by the researchers;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BPI#5; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brief pain inventory (BPI);Beck depression inventory for depression evaluation;Patient Global Impression Change (PGIC) score;Drug usage;In-vivo retention rate of the peripheral nerve stimulation system;Investigator's evaluation of operational performance of investigational equipment; | — |
Countries
China
Contacts
Chinese People's Liberation Army Eastern Theater Command General Hospital